Blaustein Robert bought EWTX
January 21, 2025 · Form 4 insider transaction
Blaustein Robert bought 30,000 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderBlaustein Robert
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 21, 2025
Filing dateJanuary 23, 2025
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on January 21, 2026.